Reuters logo
BRIEF-Zealand Pharma says diabetes drug Lyxumia approved in Europe
February 4, 2013 / 7:11 AM / in 5 years

BRIEF-Zealand Pharma says diabetes drug Lyxumia approved in Europe

Feb 4 (Reuters) - Zealand Pharma A/S : * Announces once-daily lyxumia (lixisenatide) approved in Europe for the

treatment of type 2 diabetes * Under the agreement with Sanofi, the company is entitled to tiered low double-digit percentage royalties on global sales of Lyxumia

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below